Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

Clinical trial NCT06292858 · UNKNOWN

Trial details

NCT number: NCT06292858
Sponsor: Beijng Immunoah Pharma Tech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent or Metastatic, Advanced Solid Tumors

Start date: 2023-02-24
Primary completion: 2025-04-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.